Methylphenidate Hydrochloride 00591-3873-19
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 30, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA208861
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 30 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
00591-3873-19Selected90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0591-3873-19)